Source register
Trace the words to their source.
A description needs context. This register connects the original public product records, professional guidance and regulatory explanations with the articles and examples that cite them. Product versions and source limits remain part of each reading.
Provider product page · Checked 2026-09-27
CoreAge Rx Pore Favor product description
Read the original documentArticles citing this source
Provider offer page · Checked 2026-09-27
CoreAge Rx Pore Favor current offer
Read the original documentArticles citing this source
- CoreAge Rx Pore Favor: reading a clogged-pore offer
- Clogged-pore products by format: a disclosed commercial shortlist
- Why scrubbing harder does not tell you whether a pore product works
- A useful record for a pore-product follow-up
- Salicylic-product claims and visible pores: what result is being promised?
Manufacturer product and acne-treatment labeling · Checked 2026-09-27
The Ordinary Salicylic Acid 2% Solution: current US product
Read the original documentArticles citing this source
Manufacturer product page · Checked 2026-09-27
CeraVe Acne Control Cleanser: exact US product
Read the original documentArticles citing this source
Official labeling record; revised March 2025 · Checked 2026-09-27
CeraVe Acne Control Cleanser: L’Oreal Drug Facts record
Read the original documentArticles citing this source
Regulator explanation · Checked 2026-09-27
FDA: compounding questions and answers
Read the original documentArticles citing this source
Medical society patient guidance · Checked 2026-09-27
American Academy of Dermatology: moisturizer and acne treatment
Read the original documentArticles citing this source
Medical society patient guidance · Checked 2026-09-27
American Academy of Dermatology: making pores less noticeable
Read the original documentArticles citing this source
- CoreAge Rx Pore Favor: reading a clogged-pore offer
- Clogged-pore products by format: a disclosed commercial shortlist
- CeraVe Acne Control Cleanser: interpreting the pore claims
- The Ordinary Salicylic Acid 2% Solution: a pore-language review
- Visible pores and blackheads: the words describe different questions
- Why scrubbing harder does not tell you whether a pore product works
- A useful record for a pore-product follow-up
- Salicylic-product claims and visible pores: what result is being promised?
Regulator consumer labeling guidance · Checked 2026-09-27
FDA: reading an OTC Drug Facts label
Read the original documentArticles citing this source
Clinical category explanations; not an image-based assessment · Checked 2026-09-27
American Academy of Dermatology: Acne signs and symptoms
Read the original documentArticles citing this source
General ingredient and professional-assessment guidance; updated January 10, 2023 · Checked 2026-09-27
American Academy of Dermatology: Adult acne treatment
Read the original documentArticles citing this source
Professional guidance; updated February 6, 2026; no schedule or technique reproduced · Checked 2026-09-27
American Academy of Dermatology: Exfoliation guidance
Read the original documentArticles citing this source
General irritation and acne context; not a personalized regimen · Checked 2026-09-27
American Academy of Dermatology: Habits that can worsen acne
Read the original documentArticles citing this source
Professional guidance updated January 22, 2024; urgent and emergency examples, not complete triage · Checked 2026-09-27
American Academy of Dermatology: Rash and medical-attention signs
Read the original documentArticles citing this source
General history, question and follow-up-channel guidance; updated August 18, 2023 · Checked 2026-09-27